7 Min Read
Social media users have been sharing posts which claim that “hydroxychloroquine is now ok” yet the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH) and the American Medical Association (AMA) told Reuters that their guidance advising against treating COVID-19 with hydroxychloroquine or urging caution reflects their current positions, as of this article’s publication.
Examples of the posts can be seen here , here and here .
Hydroxychloroquine is a medicine that is FDA-approved to treat arthritis and to treat or prevent malaria (here). Former U.S. President Trump said last March that hydroxychloroquine could be a game-changer in the coronavirus pandemic. He also said he was taking it himself, even after the FDA advised that its efficacy and safety were unproven (here).
In-Depth: Two ways the U.S. could accelerate vaccinations
Experts weigh the impact of syringes and pooling
Pharmacy groups say there are simple ways to maximize our COVID-19 vaccine supply, including ultra-thin needles that can extract every drop in a vial.
and last updated 2021-04-07 22:16:37-04
SAN DIEGO (KGTV) Millions of Americans are getting a COVID-19 vaccine every day but pharmacy groups say there are still ways the U.S. could maximize its supply and prevent viable doses from going to waste.
Although some states are on pace to vaccinate all willing adults by mid-summer, others are proceeding at a much slower rate that could stretch until late 2021. Experts say two efforts to improve efficiency could free up hundreds of thousands of shots per day, allowing the U.S. to export unneeded doses to other countries in desperate shape.
To embed, copy and paste the code into your website or blog:
On March 29, 2021, Judge Margaret B. Seymour, in the United States District Court for the District of South Carolina, set aside a decision from CMS’s Provider Reimbursement Review Board (Board) denying reimbursement relating to a hospital’s pharmacy residency program. The issue before the court was whether the Medical University Hospital Authority (MUHA) “operated” its pharmacy residency program under the requirements of 42 C.F.R. § 413.85(f)(1) such that MUHA was entitled to reimbursement for the pass-through costs of that program. The court determined that the Board construed section 413.85(f)(1) “too narrowly” and that MUHA was entitled to Medicare reimbursement because it was the operator of the program. The hospital was represented by Dan Hettich of King & Spalding in conjunction with local counsel.
(Photo by Kathrin Ziegler/Getty Images)
The practice known as white bagging is exacerbating supply chain security challenges and jeopardizing patient safety, the American Society of Health-System Pharmacists and the American Hospital Association told acting Food and Drug commissioner Dr. Janet Woodcock in a March 31 letter.
ASHP and AHA strongly encouraged the FDA to consider the patient safety and supply chain security risks of white bagging, and take appropriate enforcement action, according to the March 31 letter sent by AHA Executive Vice President Thomas P. Nickels and Tom Kraus, vice president of Government Relations for the American Society of Health-System Pharmacists.
GTMRx Institute Launches National Task Force to Build Vaccine Confidence
The Get the Medications Right™ Institute convenes leaders at today s BPC event to inform the public s views on vaccination safety, effectiveness, and trust
News provided by
Share this article
Share this article
TYSONS CORNER, Va., April 6, 2021 /PRNewswire/ Today, the Get the Medications Right™ (GTMRx) Institute launched a national task force to identify and address the reasons why 45% of Americans don t feel confident about vaccination against COVID-19. The GTMRx National Task Force: Building Vaccine Confidence in the Medical Neighborhood is designed to forge partnerships with trusted members of the medical neighborhood physicians, nurses, pharmacists and others on the patient care team, as well as public health leaders, social workers, consumer health advocates, social marketing and community health champions and equip them with tools and messages to build confidence in COVID-19 vaccines.